ClinConnect ClinConnect Logo
Search / Trial NCT03294811

A Two-way Communication System to Coach Elderly Patients With Heart Failure

Launched by HASSELT UNIVERSITY · Sep 26, 2017

Trial Information

Current as of April 26, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 60
  • Patient has to be followed in Ziekenhuis Oost-Limburg or Jessa Ziekenhuis Hasselt and has to live in the region Genk - Hasselt
  • The patient has to be cognitive strong enough and speak enough Dutch to communicate about their health situation and to understand the smartphone application
  • The diagnosis of systolic heart failure or severe myocardial infarction has to be done during consultation or hospitalization
  • Left ventricular ejection fraction (LVEF) \<45%
  • Treatment minimally with ACE-I and BB On the basis of an interview between the heart failure nurse and patient, one will decide if the patient is eligible to join the study. The patient also needs to speak sufficient Dutch to be communicative about his/her medical condition.
  • Exclusion Criteria:
  • Reversible form of heart failure
  • Heart failure due to severe aortic stenosis
  • At the time of inclusion a eGFR less than 30ml/min/kg
  • Presence of a cardiac resynchronization therapy (CRT) device
  • Active treatment with either ACE-I/ARB or BB
  • Patient that are subscribed in a cardiac revalidation program when leaving the hospital
  • Patients with severe form of COPD (GOLD III)

About Hasselt University

Hasselt University is a prestigious research institution located in Belgium, renowned for its commitment to advancing scientific knowledge and innovation. With a strong focus on interdisciplinary research, the university actively engages in clinical trials that aim to address pressing health challenges. Leveraging a robust network of collaborations with healthcare professionals, industry partners, and research organizations, Hasselt University strives to translate research findings into practical applications that benefit patient care and public health. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its clinical research endeavors.

Locations

Genk, , Belgium

Hasselt, , Belgium

Patients applied

0 patients applied

Trial Officials

Vandervoort Pieter, MD, PhD

Study Director

Ziekenhuis Oost-Limburg

Paul Dendale, MD, PhD

Study Director

Jessa Ziekenhuis, Hasselt, Belgium

Jo Ravelingen

Study Director

Remedus, Aartselaar, Belgium

Peter Van Vooren

Study Director

Fifthplay, Antwerpen, Belgium

Valerie Storms, PhD

Study Director

Mobile Health Unit, Hasselt University, Hasselt, Belgium

Lars Grieten, PhD

Principal Investigator

Mobile Health Unit, Hasselt University, Hasselt, Belgium

Christophe Smeets, PhD student

Study Chair

Mobile Health Unit, Hasselt University, Hasselt, Belgium

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials